Success Stories: Thanks to Our Team’s Excellent Case Preparation, NIW Approval was Won for an Egyptian Research Fellow in Biomedical Engineering

Client’s Testimonial:

“The attorneys at Chen Immigration were very pleasant to work with and always responsive to my questions. Had I known that the process would be extremely smooth, I would have committed to filing earlier in my career. I would, with no hesitation, recommend them to anyone considering applying for permanent residency.”

On October 20^th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Biomedical Engineering (Approval Notice).

General Field: Biomedical Engineering

Position at the Time of Case Filing: Research Fellow

Country of Origin: Egypt

State of Residence at the Time of Filing: Arizona

Approval Notice Date: October 20^th, 2022

Processing Time: 9 months, 8 days

Case Summary:

An EB2-NIW (National Interest Waiver) case was won for a research fellow in biomedical engineering from Egypt. This was made possible by our team’s diligent work on her petition writing, which included some of the following details:

An expert in the field of biomedical engineering, the client’s proposed endeavor is to continue to leverage her expertise in biomaterials and regenerative tissue engineering to curate novel treatment methods that are minimally harmful and effective for clinical use.
Her research is of great value because it helps to treat cancer while reducing the harmful side effects of chemotherapy and addresses common orthopedic injuries.

This is why two of her 4 recommenders had the following to say about her work:

“[The client], through her research on ACL injuries, has created a novel solution to integrate ligament tissue using biomaterials. In effect, she has given athletes a faster, more effective solution for ACL injuries without the risks from autografts and allografts, making [the client] one of the most distinguished modern biomedical engineers.”

“[The client’s] research provides an answer to one of the world’s leading causes of death: cancer. [The client’s] research provides an important molecular drug design to address rising cancer cases. She has developed a more advanced method to administer chemotherapeutic drugs to cancer patients, avoiding many of the unpleasant and often lethal side effects of traditional chemotherapy. Therefore, she has undeniably advanced global health and the biomedical engineering field through her drug research.”

Her proposed endeavor also has broad implications for the United States since her research promotes orthopedic wound healing and the health of athletes in addition to helping to improve arthritis treatments.
Her research has resulted in 3 peer-reviewed journal articles (1 of them first-authored) and 1 conference paper. These publications have also been cited 60 times already by researchers all over the world.
She has pursued research directly related to her proposed endeavor of leveraging her expertise in biomaterials and regenerative tissue engineering for 7 years, which has given her the necessary expertise to continue her work here in the U.S.
We were also able to gather evidence of her major funding source namely the National Institutes of Health.

Due to the inherent value of her work, another one of her recommenders said:

“Because of the large ACL injury incidence in the United States, [the client’s] research is essential for American athletes and sports teams to thrive after injury. Her research has opened the doors for safer, more efficient treatment methods for ACL injuries, advancing modern medicine and the biomedical engineering field as a whole. Given the significance of her work for American healthcare, the United States would be remiss to disrupt her critical biomedical engineering research.”

These details helped us prove beyond reasonable doubt that she was an excellent researcher and that her work in biomedical engineering was of benefit to the U.S. We are glad to have worked with her and we wish her the best of luck.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.